Status:
COMPLETED
Mass Screening for the Early Detection of Patients With Celiac Disease.
Lead Sponsor:
Biomedal S.L.
Collaborating Sponsors:
University of Seville
FUNDACION IHP
Conditions:
Celiac Disease
Eligibility:
All Genders
2-18 years
Brief Summary
The use of a home rapid test for the detection of both gluten immunogenic peptides (GIP) in urine and immunoglobulin A (IgA) anti tissue transglutaminase (anti-tTG) antibodies in blood may contribute ...
Detailed Description
Hypothesis: the use of a home rapid test for the detection of both gluten immunogenic peptides (GIP) in urine and IgA anti-tTG antibodies in blood may contribute to the early detection of volunteers w...
Eligibility Criteria
Inclusion
- Children and adolescents volunteers (2-18 years old).
- Regular gluten consumption.
- Willingness to perform the study and ability to collect urine samples.
- The signing of the informed consent by the volunteer and his/her legal guardians.
Exclusion
- Related diseases or psychiatric alterations which do not recommend being included in the study as the researcher's consideration.
- Lack of foreseeable collaboration.
- Patients which do not provide samples or surveys in 70% of cases.
Key Trial Info
Start Date :
December 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05186038
Start Date
December 18 2021
End Date
December 31 2022
Last Update
April 29 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
37th Celiac Festival
Madrid, Spain, 28011
2
Grupo IHP
Seville, Spain, 41014